10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 341 filers reported holding 10X GENOMICS INC in Q2 2021. The put-call ratio across all filers is 0.17 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $29,319,000 | +6.0% | 149,724 | -2.0% | 0.03% | -3.0% |
| Q1 2021 | $27,649,000 | +34.0% | 152,758 | +4.8% | 0.03% | +22.2% |
| Q4 2020 | $20,636,000 | +11.3% | 145,733 | -2.0% | 0.03% | -6.9% |
| Q3 2020 | $18,537,000 | +54.5% | 148,674 | +10.7% | 0.03% | +38.1% |
| Q2 2020 | $11,998,000 | +43.3% | 134,340 | 0.0% | 0.02% | +16.7% |
| Q1 2020 | $8,372,000 | -32.5% | 134,340 | -17.4% | 0.02% | -18.2% |
| Q4 2019 | $12,400,000 | +44.7% | 162,625 | -4.3% | 0.02% | +144.4% |
| Q3 2019 | $8,568,000 | – | 170,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |